Twinbeech Capital LP Axonics, Inc. Transaction History

Twinbeech Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $1.01 Million - $1.3 Million	20,365 Added 84.54%	44,455 $2.77 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $1.17 Million - $1.51 Million	24,090 New	24,090 $1.35 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $5.71 Million - $7.31 Million	108,576 Added 497.71%	130,391 $7.11 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $1.77 Million - $2.28 Million	-29,782 Reduced 57.72%	21,815 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $2.99 Million - $4.03 Million	51,597 New	51,597 $3.63 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $1.75 Million - $2.5 Million	-39,897 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $2 Million - $2.93 Million	39,897 New	39,897 $2.23 Million

217

41.6M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.